Had a great time at EHA learning about myeloma and presenting research showing we need to do more to help out MGUS patients. Ran into another @bloodc fellow @rinathekat and discussed research and pizza. So long Stockholm!
@Xeon4f145d96s1 Don't we have a shortage of doctors? Even if there are problems in specialty training recruitment, surely not worth creating a bigger problem in healthcare provision to make this specific issue smaller?
I'm in a video! Apologies to all my friends and colleagues who will now have to put up with a one track conversation for at least the next three years :D
@ManniMD1@VPrasadMDMPH Agree, however it's a non-zero sum game. The pots of money available to researchers and to homeless support charities providing proven interventions are unlikely to overlap.
A new blood test is being developed @unibirmingham to help diagnose a form of incurable blood cancer, myeloma.
@traceychan_1 says these could be relatively low cost and may also be done at a patient's local GP surgery.
https://t.co/UQkVuGEvsc
It's Myeloma Awareness Week, and we want showcase some of the vital research you help to fund.
Sarah was diagnosed with MGUS (monoclonal gammopathy of undetermined significance) in her twenties, and Chris is studying why some types of MGUS develop into myeloma ๐
@DrElaineVickers@andrewgregory The story here is not what was reported. Poor control arm treatment leading to worse outcomes. Lack of head to head trials etc
Wow
Minimal change disease RIP
Roughly half (higher in kids?) = anti nephrin podocytopathy
Multicentre study validating @AstridWeins et al findings at #ERA24 in @NEJM
https://t.co/BRYryNvald
@doctorhelgi It's my biggest trigger ๐ฌ especially with haem patients who will start a series of chemos @IDiots_pod do a great episode on pen allergy
@richardbuka Currently reading superior by Angela Saini--she thinks there has been a reinvention of the Neanderthal ever since it was found that predominantly Europeans raised young with neanderthals.